What drugs does ADARE PHARMS INC make?

ADARE PHARMS INC has 3 FDA-approved drugs.

What therapeutic areas does ADARE PHARMS INC focus on?

ADARE PHARMS INC focuses primarily on Cardiovascular and Neurology.

← Back

Data updated: Mar 10, 2026

ADARE PHARMS INC

CardiovascularNeurology

Generics

ADARE PHARMS INC is a generic drug manufacturer focused on Cardiovascular, Neurology.

2004

Since

Drugs

Trials

Approved (2yr)

Key Drugs

No active drugs

Recent Activity

PROPRANOLOL HYDROCHLORIDE 2026-01-27

POTASSIUM CHLORIDE 2025-12-22

POTASSIUM CHLORIDE 2025-11-20

POTASSIUM CHLORIDE 2025-10-27

Labeling

POTASSIUM CHLORIDE 2025-09-10

POTASSIUM CHLORIDE 2025-07-22

POTASSIUM CHLORIDE 2025-07-11

PROPRANOLOL HYDROCHLORIDE 2025-05-08

Labeling

POTASSIUM CHLORIDE 2025-04-21

Labeling

DEXMETHYLPHENIDATE HYDROCHLORIDE 2025-04-09

Labeling

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 50%

1 drugs

Neurology 50%

1 drugs

Pipeline Strength ProEarly access

Competitors ProEarly access

GE HEALTHCARE specialty

Neurology, Cardiovascular

Novo Nordisk big-pharma

Cardiovascular, Neurology

LEDERLE big-pharma

Cardiovascular, Neurology

PAI HOLDINGS PHARM big-pharma

Neurology, Cardiovascular

VALIDUS PHARMS specialty

Cardiovascular, Neurology

ADARE PHARMS INC

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (3)

Active (1)

Discontinued (2)

Company Info